Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, Zahed H, Guida F, Wang R, Bassett JK, Stevens V, Wang Y, Weinstein S, Freedman ND, Chen C, Tinker L, Nøst TH, Koh WP, Muller D, Colorado-Yohar SM, Tumino R, Hung RJ, Amos CI, Lin X, Zhang X, Arslan AA, Sánchez MJ, Sørgjerd EP, Severi G, Hveem K, Brennan P, Langhammer A, Milne RL, Yuan JM, Melin B, Johansson M, Robbins HA, Johansson M.
Feng X, et al.
J Natl Cancer Inst. 2023 Sep 7;115(9):1050-1059. doi: 10.1093/jnci/djad071.
J Natl Cancer Inst. 2023.
PMID: 37260165
Free PMC article.